<p>N: number of studies included; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity;</p>*<p>OR with statistical significance;</p>a<p>:studies with more than 1000 participants;</p>b<p>:studies with less than 1000 participants;</p>c<p>:studies with P<sub>HWE</sub>>0.05;</p>d<p>:studies with P<sub>HWE</sub><0.05.</p
<p>Significant associations are shown in bold, Ph- p-value of Q test for heterogeneity, OR -Odds Rat...
A meta-analysis combines and compares quantitative results of a set of studies in which more or less...
<p>GC: Gynecological cancer; NC: Nasopharyngeal carcinoma; GUC: Genitourinary system cancer; GIC: Ga...
<p>num: number of studies included; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity; PB: po...
<p>N: number of studies included; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity; BC: brea...
<p>OR: odds ratio; P: p value of heterogeneity; HB: hospital-based; PB: population-based;</p>*<p>sig...
<p>Meta-analysis results by different categories, showing the number observations used, the pooled e...
<p>N: number of studies included; OR: odds ratio; Ph: p value for heterogeneity; BC: breast cancer; ...
<p>GIC: Gastrointestinal cancer; GC: Gynecological cancer; BC: Breast cancer; HNC: Head and neck can...
*<p>P<sub>OR</sub> value for the odds ratio.</p>#<p>P<sub>H</sub> the P value of the Heterogeneity t...
<p>OR: odds ratio; P: p value of heterogeneity; HB: hospital-based; PB: population-based;</p>*<p>sig...
*<p>Meta-regression indicates the between-study variance.</p>**<p>Includes studies without enough da...
<p>P<sub>HWE</sub> was calculated by goodness-of fit χ<sup>2</sup>-test, P<sub>HWE</sub> <0.05 was c...
<p>GC: Gynecological cancer; NC: Nasopharyngeal carcinoma; GUC: Genitourinary system cancer; GIC: Ga...
1<p> in the all-studies meta-analysis in 256/1107 meta-analyses. In 199/256 (78%), also in the meta...
<p>Significant associations are shown in bold, Ph- p-value of Q test for heterogeneity, OR -Odds Rat...
A meta-analysis combines and compares quantitative results of a set of studies in which more or less...
<p>GC: Gynecological cancer; NC: Nasopharyngeal carcinoma; GUC: Genitourinary system cancer; GIC: Ga...
<p>num: number of studies included; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity; PB: po...
<p>N: number of studies included; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity; BC: brea...
<p>OR: odds ratio; P: p value of heterogeneity; HB: hospital-based; PB: population-based;</p>*<p>sig...
<p>Meta-analysis results by different categories, showing the number observations used, the pooled e...
<p>N: number of studies included; OR: odds ratio; Ph: p value for heterogeneity; BC: breast cancer; ...
<p>GIC: Gastrointestinal cancer; GC: Gynecological cancer; BC: Breast cancer; HNC: Head and neck can...
*<p>P<sub>OR</sub> value for the odds ratio.</p>#<p>P<sub>H</sub> the P value of the Heterogeneity t...
<p>OR: odds ratio; P: p value of heterogeneity; HB: hospital-based; PB: population-based;</p>*<p>sig...
*<p>Meta-regression indicates the between-study variance.</p>**<p>Includes studies without enough da...
<p>P<sub>HWE</sub> was calculated by goodness-of fit χ<sup>2</sup>-test, P<sub>HWE</sub> <0.05 was c...
<p>GC: Gynecological cancer; NC: Nasopharyngeal carcinoma; GUC: Genitourinary system cancer; GIC: Ga...
1<p> in the all-studies meta-analysis in 256/1107 meta-analyses. In 199/256 (78%), also in the meta...
<p>Significant associations are shown in bold, Ph- p-value of Q test for heterogeneity, OR -Odds Rat...
A meta-analysis combines and compares quantitative results of a set of studies in which more or less...
<p>GC: Gynecological cancer; NC: Nasopharyngeal carcinoma; GUC: Genitourinary system cancer; GIC: Ga...